Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
Enabling the Rise of a CRISPR World
As the World Debates Genome Editing Regulations, the Scientific Community Continues the Push to Democratize CRISPR
Pushing the Right Buttons
Improving Efficacy of Therapeutic DNA Vectors
For full access to this article login to GEN Select now.
Maintaining Biocontamination Control
Firms Must Demonstrate to Both the FDA and the Public that Processes are Safe and Effective
- Common wisdom holds that bacteria and viruses are everywhereexcept, of course, in bioprocesses. Keenly aware of this, biomanufacturers have numerous approaches to limiting biocontamination upstream and eliminating it to undetectable levels downstream. Processes stay clean mostly by assuring that microbes never enter the picture. Well-known techniques, such as clean-in-place, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.